Fujifilm kicks off Humira biosim project; France sees spike in healthcare IPOs;

@FierceBiotech: Who thinks they've got the tonic for Big Pharma social media headaches? This guy does: Piece | Follow @FierceBiotech

@JohnCFierce: VC boom: U.K. charity births $80M biotech fund for cancer drug research--I count $730M in new U.K./euro funds this month. Story | Follow @JohnCFierce

@RyanMFierce: Moscow backs clones of Western biotech programs in Russia. More | Follow @RyanMFierce

@FierceMedDev: Roche raises bid for U.S. diagnostics firm Illumina - San Jose Mercury News. Article | Follow @FierceMedDev

> Japan's Kyowa Hakko Kirin and Fujifilm have initiated their biosimilars joint venture, with an initial focus on Abbott's ($ABT) Humira. Story

> Seattle's Accelerator has tapped David McElligott as its new CSO. He replaces Patrick Gray, who took a position at Omeros. News

> Now that DBV Technologies has priced its shares, France has recorded its fourth healthcare IPO in the quarter, the most for any quarter in at least 20 years. Story

> Nile Therapeutics says its Phase I study for an experimental heart drug met its endpoint. Report

Pharma News

@FiercePharma: Who could make a play for Amylin next? AstraZeneca and Sanofi, per analysts. Bristol-Myers may return, too. Article | Follow @FiercePharma

> Allergan asks FDA for lucrative new Botox indication. Item

> Judge denies AZ's bid to stop Seroquel copies, but chides FDA. News

> Who's next to move on Amylin? Analysts say Big Pharma looms. Story

CRO News

> Parexel should see more revenue, higher share prices, analysts say. More

> Cetero sees strong future despite bankruptcy protection filing. Article

> INC Research axes staffers, closes Connecticut lab. Story

> Spaulding's hand-held ECG fuels tax credits and hiring boom. Item

> Report sheds light on pharma and CRO trial enrollment woes. News

Vaccines News

> Vaxfectin-based malaria vaccine could stop transmission. Item

> Narcolepsy spike linked with flu shot. Story

> Academics' oral stomach flu vax could save lives. Article

> Genetic tweaking could create chlamydia vaccine. More

Manufacturing News

> CMC, third-party manufacturing issues delay Map drug launch. News

> California implant makers get FDA warnings. Article

> Novartis plant disruptions affect pet treatments. Story

> Sandoz Canada president explains shortages to House of Commons. Article

> Halo agrees to buy Teva's Montreal facility. Report

And Finally… An international group of investigators is working on a new "micro-robot" designed to detect diseases. Release

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.